These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18697946)

  • 21. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
    Nepom BS; Nepom GT; Coleman M; Kwok WW
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9.
    James EA; Moustakas AK; Bui J; Nouv R; Papadopoulos GK; Kwok WW
    J Immunol; 2009 Sep; 183(5):3249-58. PubMed ID: 19648278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative molecular and three-dimensional analysis of the peptide-MHC II binding region in both human and Aotus MHC-DRB molecules confirms their usefulness in antimalarial vaccine development.
    Patarroyo ME; Cifuentes G; Baquero J
    Immunogenetics; 2006 Jul; 58(7):598-606. PubMed ID: 16791622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation.
    Faner R; James E; Huston L; Pujol-Borrel R; Kwok WW; Juan M
    Eur J Immunol; 2010 Jan; 40(1):91-102. PubMed ID: 19830726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
    Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
    J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis.
    Maier JT; Haug M; Föll JL; Beck H; Kalbacher H; Rammensee HG; Dannecker GE
    Immunogenetics; 2002 May; 54(2):67-73. PubMed ID: 12037598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation.
    Trembleau S; Giacomini P; Guéry JC; Setini A; Hammer J; Sette A; Appella E; Adorini L
    Int Immunol; 1995 Dec; 7(12):1927-38. PubMed ID: 8746562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy.
    Zerva L; Cizman B; Mehra NK; Alahari SK; Murali R; Zmijewski CM; Kamoun M; Monos DS
    J Exp Med; 1996 Mar; 183(3):829-36. PubMed ID: 8642287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structures of an MHC class II molecule with covalently bound single peptides.
    Fremont DH; Hendrickson WA; Marrack P; Kappler J
    Science; 1996 May; 272(5264):1001-4. PubMed ID: 8638119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules.
    Zhang L; Chen Y; Wong HS; Zhou S; Mamitsuka H; Zhu S
    PLoS One; 2012; 7(2):e30483. PubMed ID: 22383964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
    Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
    J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach.
    Patronov A; Dimitrov I; Flower DR; Doytchinova I
    BMC Struct Biol; 2011 Jul; 11():32. PubMed ID: 21752305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor.
    Nagvekar N; Corlett L; Jacobson LW; Matsuo H; Chalkley R; Driscoll PC; Deshpande S; Spack EG; Willcox N
    J Immunol; 1999 Apr; 162(7):4079-87. PubMed ID: 10201931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
    Kropshofer H; Bohlinger I; Max H; Kalbacher H
    Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs.
    Zaheer-ul-Haq ; Khan W
    J Comput Aided Mol Des; 2011 Jan; 25(1):81-101. PubMed ID: 21116684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins.
    Harris PE; Maffei A; Colovai AI; Kinne J; Tugulea S; Suciu-Foca N
    Blood; 1996 Jun; 87(12):5104-12. PubMed ID: 8652823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.